Jacky Vonderscher
![Jacky Vonderscher Jacky Vonderscher](https://ckd3-summit.com/wp-content/uploads/sites/28/2024/02/jacky_vonderscher-150x150.jpg)
Company: ENYO Pharma
Job title: Co-Founder and Chief Executive Officer
Seminars:
Developing antifibrotic and anti-inflammatory therapeutics in clinical stage for common and rare renal diseases including CKD and Alport syndrome 11:30 am
Developing Vonafexor in the Proof-Of-Concept Phase 2 study “ALPESTRIA-1” in Alport syndrome Validating efficacy of Vonafexor on kidney function and kidney remodeling in a severe preclinical mouse model for CKD as much as for Alport syndrome Expanding Vonafexor analog development to larger kidney indicationsRead more
day: Day 2 Track 2 AM